Completed PHASE4 INTERVENTIONAL NCT00168779

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

A Randomized, Double-blind, Placebo-controlled, Forced-titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg Taken Orally for Eight Weeks in Patients With Stage 1 or Stage 2 Hypertension.

Sponsor: Boehringer Ingelheim

Conditions Hypertension

Interventions placebo telmisartan 80 mg / hydrochlorothiazide 25 mg valsartan 160 mg / hydrochlorothiazide 25 mg

Updated 7 times since 2017 Last updated: Dec 27, 2017 Started: Sep 30, 2005 Primary completion: Jul 31, 2006 Completion: Jul 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00168779, this PHASE4 trial focuses on Hypertension and remains completed. Sponsored by Boehringer Ingelheim, it has been updated 7 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jan 2018 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Jan 2018 [monthly]

Completed PHASE4

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boehringer Ingelheim

Data source: Boehringer Ingelheim

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Athens, United States , Atlanta, United States , Berlin, United States , Birmingham, United States , Boulder, United States , Bountiful, United States , Brooklyn, United States , Brooklyn Center, United States , Buena Park, United States , Burlington, United States and 82 more locations